Articles

The Minnesota Board of Pharmacy has revised the language of an important Frequently Asked Question (FAQ) to ensure that payments to Minnesota health care practitioners for participation in bona fide market research are NOT prohibited or restricted.

The U.S. survey and research profession testified today before a joint hearing in the Minnesota House and Senate. The Marketing Research Association’s (MRA) Director of Government Affairs, Howard Fienberg, PLC, defended the use of physician incentives in pharmaceutical and medical device manufacturing.

Today, the Marketing Research Association (MRA) announces victory in its lobbying and grassroots actions to protect research with health care practitioners in Massachusetts. The Massachusetts Department of Health has issued official guidance exempting market research incentives from the application of the state’s new Marketing Code of Conduct for pharmaceutical and medical device manufacturers.

Recent regulations passed in Massachusetts will severely hurt research with healthcare practitioners. The Marketing Research Association (MRA) is calling for all members of the research profession in Massachusetts to take action now.

MRA scored several recent victories in the ongoing fight against legislation to require public reporting of survey research incentives for health care practitioners or that ban them outright. MRA recently helped to convince legislators in Maryland and Rhode Island to withdraw their bills and helped to defeat legislation in Mississippi.

The New Mexico State Senate recently defeated a bill which would have required the public reporting of incentives paid to health care professionals for participation in marketing research studies sponsored by pharmaceutical, medical device or medical supply manufacturers.

What are the federal income tax reporting requirements for incentives offered for participation in research?